The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Ivermectin, 'Wonder drug' from Japan: the human use perspective
Open accessAbstract
Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin--originating solely from a single microorganism isolated at the Kitasato Institute, Tokyo, Japan from Japanese soil--has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world's most devastating and disfiguring diseases which have plagued the world's poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin's passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a "wonder" drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug resistance in nematodes of veterinary importance: a status report
Kaplan, R. M. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.08.001 · Cited by 1,276
Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation
Burg, R. W., Miller, B. M., Baker, E. E., Birnbaum, J., Currie, S. A., Hartman, R., Kong, Y.-L., Monaghan, R. L., Olson, G., Putter, I., et al. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.3.361 · Cited by 933
Ivermectin: A Potent New Antiparasitic Agent
Campbell, W. C., Fisher, M. H., Stapley, E. O., Albers-Schönberg, G., & Jacob, T. A. (1983) · Science · doi:10.1126/science.6308762 · Cited by 825
Drug resistance in veterinary helminths
Wolstenholme, A. J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G., & Sangster, N. C. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.07.010 · Cited by 813
The genetics of ivermectin resistance in Caenorhabditis elegans
Dent, J. A., Smith, M. M., Vassilatis, D. K., & Avery, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2674 · Cited by 455
Adjuvant tamoxifen in the management of operable breast cancer : Scottish Trial
Scottish Cancer Trials Office (1987) · The Lancet · Cited by 428
Ivermectin: 25 years and still going strong
Õmura, S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.023 · Cited by 338
Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis
Basáñez, M.-G., Pion, S. D., Boakes, E., Filipe, J. A., Churcher, T. S., & Boussinesq, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70099-9 · Cited by 336
Ivermectin, a new broad-spectrum antiparasitic agent
Chabala, J. C., Mrozik, H., Tolman, R. L., Eskola, P., Lusi, A., Peterson, L. H., Woods, M. F., Fisher, M. H., & Campbell, W. C. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00184a014 · Cited by 329
Ivermectin 20 years on: maturation of a wonder drug
GEARY, T. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.08.014 · Cited by 303
The life and times of ivermectin — a success story
Õmura, S., & Crump, A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1048 · Cited by 273
Self-citationC. Campbell, W. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800399095 · Cited by 245
Campbell, W. C. (1985) · Parasitology Today · doi:10.1016/0169-4758(85)90100-0 · Cited by 245
Plaisier, A. P., Alley, E. S., Boatin, B. A., Van Oortmarssen, G. J., Remme, H., De Vias, S. J., Bonneux, L., & Habbema, J. D. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.1.204 · Cited by 242
Control Strategies for Human Intestinal Nematode Infections
Albonico, M., Crompton, D. W. T., & Savioli, L. (1999) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60151-7 · Cited by 210
Turner, M. J., & Schaeffer, J. M. (1989) · Ivermectin and Abamectin · doi:10.1007/978-1-4612-3626-9_5 · Cited by 209
Immunological tolerance: The key feature in human filariasis?
Maizels, R. M., & Lawrence, R. A. (1991) · Parasitology Today · doi:10.1016/0169-4758(91)90093-4 · Cited by 189
Ottesen, E. A., & Campbell, W. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.2.195 · Cited by 181
Moreno, Y., Nabhan, J. F., Solomon, J., Mackenzie, C. D., & Geary, T. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011983107 · Cited by 173
Onchocerciasis and its control. Report of a WHO Expert Committee on onchocerciasis control
Service, M. W. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90460-3 · Cited by 157
Ectoparasites—the underestimated realm
Heukelbach, J., & Feldmeier, H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15738-3 · Cited by 136
Heukelbach, J., Winter, B., Wilcke, T., Muehlen, M., Albrecht, S., Oliveira, F. A., Kerr, L. R. F. S., Liesenfeld, O., & Feldmeier, H. (2004) · Europe PMC (PubMed Central) · Cited by 130
Of Mice, Cattle, and Humans: The Immunology and Treatment of River Blindness
Allen, J. E., Adjei, O., Bain, O., Hoerauf, A. M., Hoffmann, W. H., Makepeace, B. L., Schulz-Key, H., Tanya, V. N., Trees, A. J., Wanji, S., et al. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000217 · Cited by 121
A Controlled Trial of Ivermectin and Diethylcarbamazine in Lymphatic Filariasis
Ottesen, E. A., Vijayasekaran, V., Kumaraswami, V., Pillai, S. V. P., Sadanandam, A., Frederick, S., Prabhakar, R., & Tripathy, S. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221604 · Cited by 119
Ivermectin for the Treatment of Wuchereria bancrofti Filariasis: Efficacy and Adverse Reactions
Kumaraswami, V. (1988) · JAMA · doi:10.1001/jama.259.21.3150 · Cited by 116
The Status of Ivermectin in the Treatment of Human Onchocerciasis
Taylor, H. R., & Greene, B. M. (1989) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.41.460 · Cited by 89
IVERMECTIN AS AN ANTIPARASITIC AGENT FOR USE IN HUMANS
Campbell, W. C. (1991) · Annual Review of Microbiology · doi:10.1146/annurev.mi.45.100191.002305 · Cited by 87
A field study of the effects of ivermectin on ectoparasites of man
Dunne, C., Malone, C., & WHITWORTH, J. A. G. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90255-w · Cited by 79
Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea
Bockarie, M. J., Alexander, N. D. E., Kazura, J. W., Bockarie, F., Griffin, L., & Alpers, M. P. (2000) · Acta Tropica · doi:10.1016/s0001-706x(99)00087-x · Cited by 70
The Mectizan Donation Program (MDP)
Thylefors, B. (2008) · Annals of Tropical Medicine and Parasitology · doi:10.1179/136485908x337481 · Cited by 67
Dadzie, K. Y., Bird, A. C., Awadzi, K., Schulz-Key, H., Gilles, H. M., & Aziz, M. A. (1987) · British Journal of Ophthalmology · doi:10.1136/bjo.71.2.78 · Cited by 66
Mackenzie, C. D., Geary, T. G., & Gerlach, J. A. (2003) · Filaria Journal · doi:10.1186/1475-2883-2-s1-s5 · Cited by 60
Richards, F. O., Eberhard, M. L., Bryan, R. T., McNeeley, D. F., Lammie, P. J., McNeeley, M. B., Bernard, Y., Hightower, A. W., & Spencer, H. C. (1991) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.3 · Cited by 59
Moncayo, A. L., Vaca, M. G., Amorim, L. D. A. F., Rodríguez, A., Erazo, S., Oviedo, G., Quinzo, I., Padilla, M., Chico, M. E., Lovato, R., et al. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000293 · Cited by 58
Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin
Sáez‐de‐Ocariz, M., McKinster, C. D., Orozco‐Covarrubias, L., Tamayo‐Sánchez, L., & Ruiz‐Maldonado, R. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01050.x · Cited by 56
The chemotherapy of onchocerciasis II
Awadzi, K. (1980) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1980.11687330 · Cited by 55
DOSE-RANGING STUDY OF IVERMECTIN IN TREATMENT OF FILARIASIS DUE TO WUCHERERIA BANCROFTI
Diallo, S., Aziz, M. A., Ndir, O., Badiane, S., Bah, I. B., & Gaye, O. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92291-4 · Cited by 44
Mass treatment with ivermectin: an underutilized public health strategy.
Speare, R., & Dürrheim, D. N. (2004) · PubMed · Cited by 27
Ivermectin-derived leishmanicidal compounds
dos Santos, A. R., Falcão, C. A. B., Muzitano, M. F., Kaiser, C. R., Rossi‐Bergmann, B., & Férézou, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.003 · Cited by 25
Ōmura, S. (2003) · Elsevier eBooks · doi:10.1016/b978-012526451-8/50014-x · Cited by 23
The chemotherapy of filarial nematode infections of man: aspirations and problems.
Denham, D. A., & Barret, J. P. (1987) · Cited by 2
Cited by
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Katsuno, K., Burrows, J. N., Duncan, K., van Huijsduijnen, R. H., Kaneko, T., Kita, K., Mowbray, C. E., Schmatz, D., Warner, P., & Slingsby, B. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4683 · Cited by 607
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Heidary, F., & Gharebaghi, R. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0336-z · Cited by 435
Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00876 · Cited by 409
Kory, P., Meduri, G. U., Varon, J., Iglesias, J., & Marik, P. E. (2021) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001377 · Cited by 203
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
Henriquez-Camacho, C., Gotuzzo, E., Echevarria, J., White Jr, A. C., Terashima, A., Samalvides, F., Pérez-Molina, J. A., & Plana, M. N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007745.pub3 · Cited by 193
Metadata
- Authors
- CRUMP, A., & OMURA, S.
- Venue
- Proceedings of the Japan Academy, Series B
- Publisher
- Japan Academy
- Published
- 2011
- Volume
- 87
- Issue
- 2
- Pages
- 13-28
- ISSN
- 0386-2208 (ISSN-L)
- 1349-2896
- OpenAlex
- W1991496259
- Cited by
- 368
- References
- 42
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.